| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6455533 | J AND J CONSUMER INC | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
Jul, 2018
(5 years ago) | |
Children'S Zyrtec Allergy is owned by J And J Consumer Inc.
Children'S Zyrtec Allergy contains Cetirizine Hydrochloride.
Children'S Zyrtec Allergy has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Children'S Zyrtec Allergy are:
- US6455533
Children'S Zyrtec Allergy was authorised for market use on 30 November, 2020.
Children'S Zyrtec Allergy is available in tablet, chewable;oral dosage forms.
Children'S Zyrtec Allergy can be used as treatment of seasonal and perennial allergic rhinitis symptoms.
The generics of Children'S Zyrtec Allergy are possible to be released after 02 July, 2018.
Drugs and Companies using CETIRIZINE HYDROCHLORIDE ingredient
Market Authorisation Date: 30 November, 2020
Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms
Dosage: TABLET, CHEWABLE;ORAL
CHILDREN'S ZYRTEC ALLERGY family patents
